Boston Scientific Corporation Share Price
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.84 USD | +1.69% |
|
-0.03% | -34.38% |
| Capitalization | 91.83B 78.45B 72.34B 68.26B 127B 8,599B 130B 847B 333B 4,106B 345B 337B 14,669B | P/E ratio 2026 * |
25.4x | P/E ratio 2027 * | 21.4x |
|---|---|---|---|---|---|
| Enterprise value | 98B 83.72B 77.2B 72.85B 135B 9,177B 139B 904B 355B 4,383B 368B 360B 15,655B | EV / Sales 2026 * |
4.4x | EV / Sales 2027 * | 3.85x |
| Free-Float |
84.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +1.72% | ||
| 1 week | -0.03% | ||
| Current month | -0.29% | ||
| 1 month | -9.49% | ||
| 3 months | -33.54% | ||
| 6 months | -34.10% | ||
| Current year | -34.38% |
| 1 week | 60.59 |  | 63.54 |
| 1 month | 60.59 | | 71.94 |
| Current year | 60.59 | | 100.9 |
| 1 year | 60.59 | | 109.5 |
| 3 years | 48.35 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.34 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
John Sorenson
COO | Chief Operating Officer | 58 | 30/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sununu
BRD | Director/Board Member | 61 | 31/03/2009 |
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.82% | 1.75% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.69% | -0.03% | -33.63% | +21.50% | 91.83B | |
| +2.60% | +3.95% | +12.94% | -14.16% | 184B | |
| +1.07% | +0.53% | -7.17% | +70.69% | 160B | |
| +2.09% | +0.63% | +0.19% | -24.01% | 134B | |
| +0.05% | +5.15% | -14.70% | -30.25% | 49.47B | |
| +0.06% | -4.32% | +11.18% | -8.24% | 44.9B | |
| +0.58% | +4.30% | +14.04% | -11.47% | 33.39B | |
| +0.38% | +2.12% | +7.07% | +1.39% | 33.2B | |
| +1.55% | +1.47% | +10.78% | -17.52% | 32.52B | |
| +0.40% | +5.37% | -4.00% | +2.57% | 31.41B | |
| Average | +1.05% | +1.02% | -0.33% | -0.95% | 79.53B | |
| Weighted average by Cap. | +1.50% | +0.37% | -1.41% | +5.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.25B 19.01B 17.53B 16.54B 30.73B 2,083B 31.51B 205B 80.7B 995B 83.5B 81.73B 3,554B | 24.5B 20.93B 19.3B 18.21B 33.84B 2,294B 34.7B 226B 88.87B 1,096B 91.94B 89.99B 3,913B |
| Net income | 3.58B 3.06B 2.82B 2.66B 4.94B 335B 5.07B 33.01B 12.98B 160B 13.43B 13.14B 571B | 4.28B 3.65B 3.37B 3.18B 5.91B 401B 6.06B 39.47B 15.52B 191B 16.05B 15.71B 683B |
| Net Debt | 6.17B 5.27B 4.86B 4.59B 8.53B 578B 8.74B 56.96B 22.39B 276B 23.17B 22.68B 986B | 2.57B 2.2B 2.03B 1.91B 3.55B 241B 3.64B 23.74B 9.33B 115B 9.66B 9.45B 411B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/04/26 | 62.56 $ | +1.25% | 4,103,199 |
| 10/04/26 | 61.79 $ | +0.83% | 14,774,150 |
| 09/04/26 | 61.28 $ | -2.05% | 12,702,487 |
| 08/04/26 | 62.56 $ | +1.13% | 14,972,723 |
| 07/04/26 | 61.86 $ | -1.17% | 18,325,161 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition